• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation of the Dutch version of the Edmonton Symptom Assessment System.验证荷兰版埃德蒙顿症状评估系统。
Cancer Med. 2020 Sep;9(17):6111-6121. doi: 10.1002/cam4.3253. Epub 2020 Jul 9.
2
Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy.验证门诊版乌得勒支症状日记中 11 项新增项目在接受化疗或靶向治疗的患者中的适用性。
J Patient Rep Outcomes. 2024 Oct 18;8(1):120. doi: 10.1186/s41687-024-00794-w.
3
Do Patient Sociodemographic Factors Impact the PROMIS Scores Meeting the Patient-Acceptable Symptom State at the Initial Point of Care in Orthopaedic Foot and Ankle Patients?患者社会人口统计学因素是否会影响在骨科足踝患者初始护理点时满足患者可接受症状状态的 PROMIS 评分?
Clin Orthop Relat Res. 2019 Nov;477(11):2555-2565. doi: 10.1097/CORR.0000000000000866.
4
Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.使用埃德蒙顿症状评估系统修订版日语版确定定义症状严重程度的临界值。
J Pain Symptom Manage. 2016 Feb;51(2):292-7. doi: 10.1016/j.jpainsymman.2015.09.011. Epub 2015 Oct 24.
5
Hemorrhoidal Disease Symptom Score and Short Health ScaleHD: New Tools to Evaluate Symptoms and Health-Related Quality of Life in Hemorrhoidal Disease.痔病症状评分和简短健康量表(HD):评估痔病症状和健康相关生活质量的新工具。
Dis Colon Rectum. 2019 Mar;62(3):333-342. doi: 10.1097/DCR.0000000000001234.
6
Urethroplasty and Quality of Life: Psychometric Validation of a Dutch Version of the Urethral Stricture Surgery Patient Reported Outcome Measures.尿道成形术与生活质量:荷兰版尿道狭窄手术患者报告结局量表的心理测量学验证
Urol Int. 2017;99(4):460-466. doi: 10.1159/000479189. Epub 2017 Aug 30.
7
Validation of the Edmonton Symptom Assessment System: Ascites Modification.埃德蒙顿症状评估系统的验证:腹水改良版。
J Pain Symptom Manage. 2018 Jun;55(6):1557-1563. doi: 10.1016/j.jpainsymman.2018.03.016. Epub 2018 Mar 23.
8
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.埃德蒙顿症状评估系统身体、情感及总症状困扰评分的最小临床重要差异
J Pain Symptom Manage. 2016 Feb;51(2):262-9. doi: 10.1016/j.jpainsymman.2015.10.004. Epub 2015 Oct 19.
9
The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer.埃德蒙顿症状评估系统:在晚期癌症患者中作为重度抑郁症筛查工具的表现不佳。
Palliat Med. 2016 Jun;30(6):587-98. doi: 10.1177/0269216315620082. Epub 2016 Jan 13.
10
Evaluation of the palliative symptom burden score (PSBS) in a specialised palliative care unit of a university medical centre - a longitudinal study.评价大学医学中心专科姑息治疗病房的姑息症状负担评分(PSBS)-一项纵向研究。
BMC Palliat Care. 2018 Jul 7;17(1):92. doi: 10.1186/s12904-018-0342-0.

引用本文的文献

1
Timely integration of palliative care into oncology care for patients with bone metastases at the radiotherapy department: A pilot study on acceptability and feasibility.放疗科对骨转移癌患者姑息治疗与肿瘤治疗的及时整合:一项关于可接受性和可行性的初步研究
Tech Innov Patient Support Radiat Oncol. 2025 Jun 10;35:100317. doi: 10.1016/j.tipsro.2025.100317. eCollection 2025 Sep.
2
Use of brief, simple anxiety assessment tools in palliative care - yes, we can: a cross-sectional observational study of anxiety visual analog scale and numeric rating scale.在姑息治疗中使用简短、简单的焦虑评估工具——是的,我们可以:焦虑视觉模拟量表和数字评定量表的横断面观察研究
BMC Palliat Care. 2025 Jul 1;24(1):173. doi: 10.1186/s12904-025-01814-2.
3
Validating the socio-spiritual items of the Utrecht Symptom Diary-4 Dimensional: Content and construct validity.验证乌得勒支症状日记-4维度的社会精神项目:内容效度和结构效度。
Palliat Med. 2025 May;39(5):622-634. doi: 10.1177/02692163251321692. Epub 2025 Feb 28.
4
Experience or perception: What healthcare providers need when using the Utrecht Symptom Diary-4 Dimensional, a mixed-methods study.经验还是认知:医疗服务提供者在使用乌得勒支症状日记-4维度时的需求,一项混合方法研究。
Palliat Care Soc Pract. 2024 Oct 31;18:26323524241281748. doi: 10.1177/26323524241281748. eCollection 2024.
5
Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy.验证门诊版乌得勒支症状日记中 11 项新增项目在接受化疗或靶向治疗的患者中的适用性。
J Patient Rep Outcomes. 2024 Oct 18;8(1):120. doi: 10.1186/s41687-024-00794-w.
6
'It is important to feel invited': what patients require when using the Utrecht Symptom Diary - 4 Dimensional, a qualitative exploration.“感到被接纳很重要”:患者使用乌得勒支症状日记-4维度时的需求,一项定性探索
Palliat Care Soc Pract. 2024 Jun 20;18:26323524241260426. doi: 10.1177/26323524241260426. eCollection 2024.
7
A comparison of the prevalence of dry mouth and other symptoms using two different versions of the Edmonton Symptom Assessment System on an inpatient palliative care unit.在一家姑息治疗住院病房中,使用两种不同版本的埃德蒙顿症状评估系统比较口干和其他症状的患病率。
BMC Palliat Care. 2024 Mar 16;23(1):75. doi: 10.1186/s12904-024-01405-7.
8
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study-A Qualitative Study.睾丸生殖细胞肿瘤治疗后青少年和青年成人性功能迟发效应的观点与担忧:PRICELESS研究——一项定性研究
Cancers (Basel). 2024 Feb 8;16(4):715. doi: 10.3390/cancers16040715.
9
Measurement and documentation of quality indicators for the end-of-life care of hospital patients a nationwide retrospective record review study.测量和记录医院患者临终关怀质量指标的全国回顾性病历审查研究。
BMC Palliat Care. 2023 Nov 8;22(1):174. doi: 10.1186/s12904-023-01299-x.
10
Dry mouth in patients with a life-limiting condition or frailty: a study protocol for two intervention studies and a nested qualitative sub-study (the Dry mOuth Project, DROP).生命终末期或衰弱患者的口干症:两项干预研究和一项嵌套定性子研究的研究方案(干口项目,DROP)。
BMC Palliat Care. 2023 Aug 23;22(1):120. doi: 10.1186/s12904-023-01242-0.

本文引用的文献

1
The Optimal Cutoff Point for Expressing Revised Edmonton Symptom Assessment System Scores as Binary Data Indicating the Presence or Absence of Symptoms.将修订后的埃德蒙顿症状评估系统评分表示为表明症状存在或不存在的二元数据时的最佳截断点。
Am J Hosp Palliat Care. 2018 Nov;35(11):1390-1393. doi: 10.1177/1049909118775660. Epub 2018 May 7.
2
COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study.COSMIN 方法学用于评估患者报告结局测量的内容效度:一项德尔菲研究。
Qual Life Res. 2018 May;27(5):1159-1170. doi: 10.1007/s11136-018-1829-0. Epub 2018 Mar 17.
3
Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study.在一项关于舒尼替尼的药代动力学研究中使用患者报告的结局测量指标,一项前瞻性队列研究。
Support Care Cancer. 2018 Aug;26(8):2641-2650. doi: 10.1007/s00520-018-4075-7. Epub 2018 Feb 21.
4
Patient-reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study.表皮生长因子抑制剂治疗患者的患者报告症状及症状逐步管理:一项回顾性描述性队列研究。
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12800. doi: 10.1111/ecc.12800. Epub 2018 Jan 4.
5
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.一项评估常规癌症治疗期间症状监测的患者报告结局的试验的总生存结果。
JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.
6
The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.25年后的埃德蒙顿症状评估系统:过去、现在及未来发展
J Pain Symptom Manage. 2017 Mar;53(3):630-643. doi: 10.1016/j.jpainsymman.2016.10.370. Epub 2016 Dec 29.
7
Personalized symptom goals and response in patients with advanced cancer.晚期癌症患者的个性化症状目标与反应
Cancer. 2016 Jun 1;122(11):1774-81. doi: 10.1002/cncr.29970. Epub 2016 Mar 11.
8
Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.使用埃德蒙顿症状评估系统修订版日语版确定定义症状严重程度的临界值。
J Pain Symptom Manage. 2016 Feb;51(2):292-7. doi: 10.1016/j.jpainsymman.2015.09.011. Epub 2015 Oct 24.
9
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.一项在初治转移性黑色素瘤患者中比较纳米白蛋白结合型紫杉醇与达卡巴嗪的随机对照III期试验。
Ann Oncol. 2015 Nov;26(11):2267-74. doi: 10.1093/annonc/mdv324. Epub 2015 Sep 26.
10
The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.巴西版埃德蒙顿症状评估系统(ESAS)是一种用于测量晚期癌症患者症状的可行、有效且可靠的工具。
PLoS One. 2015 Jul 8;10(7):e0132073. doi: 10.1371/journal.pone.0132073. eCollection 2015.

验证荷兰版埃德蒙顿症状评估系统。

Validation of the Dutch version of the Edmonton Symptom Assessment System.

机构信息

Center of Expertise in Palliative Care, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, The Netherlands.

Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, University Utrecht, The Netherlands.

出版信息

Cancer Med. 2020 Sep;9(17):6111-6121. doi: 10.1002/cam4.3253. Epub 2020 Jul 9.

DOI:10.1002/cam4.3253
PMID:32643871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7476846/
Abstract

BACKGROUND

The Utrecht Symptom Diary (USD) is a Dutch and adapted version of the Edmonton Symptom Assessment System, a patient-reported outcome measurement (PROM) tool to asses and monitor symptoms in cancer patients. This study analyses the validity and responsiveness of the USD and the cutoff points to determine the clinical significance of a symptom score.

METHODS

Observational longitudinal cohort study including adult in- and outpatients treated in an academic hospital in the Netherlands who completed at least one USD as part of routine care (2012-2019). The distress thermometer and problem checklist (DT&PC) was used as a reference PROM. Content, construct and criterion validity, responsiveness, and cutoff points are shown with prevalences, area under receiver operating characteristic (ROC) curve, Chi-squared test, Wilcoxon signed-rank test, and positive and negative predictive values, respectively.

RESULTS

A total of 3913 patients completed 22 400 USDs. Content validity was confirmed for all added USD items with prevalences of ≥22%. All USD items also present on the DT&PC demonstrated a good criterion validity (ROC >0.8). Construct validity was confirmed for the USD as a whole and for the items dry mouth, dysphagia and well-being (P < .0001). USD scores differed significantly for patients when improving or deteriorating on the DT&PC which confirmed responsiveness. Optimal cutoff points (3 or 4) differed per symptom.

CONCLUSION

The USD is a valid 12-item PROM for the most prevalent symptoms in cancer patients, which has content, criterion, and construct validity, and detects clinically important changes over time, in both curative and palliative phase.

摘要

背景

乌得勒支症状日记(USD)是埃德蒙顿症状评估系统的荷兰语和改编版本,是一种患者报告的结局测量(PROM)工具,用于评估和监测癌症患者的症状。本研究分析了 USD 的有效性和反应性以及截断值,以确定症状评分的临床意义。

方法

这是一项观察性纵向队列研究,纳入了在荷兰一家学术医院接受治疗的成年住院和门诊患者,他们在常规护理中至少完成了一次 USD(2012-2019 年)。使用痛苦温度计和问题清单(DT&PC)作为参考 PROM。显示内容、结构和标准有效性、反应性和截断值的方法分别为流行率、接收器操作特征(ROC)曲线下面积、卡方检验、Wilcoxon 符号秩检验以及阳性和阴性预测值。

结果

共有 3913 名患者完成了 22400 次 USD。所有新增 USD 项目的内容有效性均得到确认,其流行率均≥22%。所有在 DT&PC 上出现的 USD 项目也具有良好的标准有效性(ROC >0.8)。USD 作为一个整体以及口干、吞咽困难和幸福感等项目的结构有效性得到了确认(P<.0001)。当 DT&PC 上的患者病情改善或恶化时,USD 评分存在显著差异,这证实了其反应性。每个症状的最佳截断值(3 或 4)不同。

结论

USD 是一种针对癌症患者最常见症状的有效 12 项 PROM,具有内容、标准和结构有效性,并且可以检测到随着时间推移的临床重要变化,无论是在治疗期还是姑息期。